Published in J Surg Res on January 20, 2009
Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden. Surgery (2013) 1.16
Improvement of survival and prospect of cure in patients with metastatic breast cancer. Breast Cancer (2011) 1.15
Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival. Ann Surg Oncol (2013) 0.86
SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation. BMC Surg (2012) 0.86
Does removal of the primary tumor in metastatic breast cancer improve survival? J Womens Health (Larchmt) (2013) 0.86
Factors associated with better survival after surgery in metastatic breast cancer patients. Indian J Surg Oncol (2012) 0.83
Cox models survival analysis based on breast cancer treatments. Iran J Cancer Prev (2014) 0.76
Exclusive and adjuvant radiotherapy in breast cancer patients with synchronous metastases. BMC Cancer (2010) 0.75
Excision of the primary tumour in patients with metastatic breast cancer: a clinical dilemma. Curr Oncol (2012) 0.75
Hormone receptor status may impact the survival benefit of surgery in stage iv breast cancer: a population-based study. Oncotarget (2016) 0.75
The role and indications of aggressive locoregional therapy in metastatic inflammatory breast cancer. Sci Rep (2016) 0.75
Therapeutic role of axillary lymph node dissection in patients with stage IV breast cancer: a population-based analysis. J Cancer Res Clin Oncol (2016) 0.75
Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol (2008) 6.31
Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. J Clin Oncol (2012) 4.33
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. Lancet Oncol (2013) 2.59
Improvement in oncology practice performance through voluntary participation in the Quality Oncology Practice Initiative. J Clin Oncol (2008) 2.39
The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol (2011) 2.37
Linkage of gut microbiome with cognition in hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol (2011) 2.23
Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol (2005) 2.17
Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice. Int Immunopharmacol (2009) 2.14
Sublingual tissue perfusion improves during emergency treatment of acute decompensated heart failure. Am J Emerg Med (2011) 2.08
A signature of immune function genes associated with recurrence-free survival in breast cancer patients. Breast Cancer Res Treat (2011) 1.99
The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy. Hepatology (2013) 1.92
Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology (2012) 1.74
Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J Hepatol (2013) 1.66
GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells. Breast Cancer Res Treat (2009) 1.60
Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. J Clin Oncol (2008) 1.42
Breast conservation therapy rates are no different in medically indigent versus insured patients with early stage breast cancer. J Surg Oncol (2003) 1.39
Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors. Cancer Res (2008) 1.38
Supporting Play Exploration and Early Development Intervention From NICU to Home: A Feasibility Study. Pediatr Phys Ther (2015) 1.37
Genetic research in the blood bank: acceptability to Northern California donors. Transfusion (2010) 1.36
New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology (2013) 1.35
Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells. Cancer Immunol Immunother (2008) 1.30
Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function. J Transl Med (2009) 1.26
Left ventricular systolic dysfunction induced by ventricular ectopy: a novel model for premature ventricular contraction-induced cardiomyopathy. Circ Arrhythm Electrophysiol (2011) 1.17
Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology (2014) 1.16
Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden. Surgery (2013) 1.16
Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity. J Immunol (2012) 1.15
The Living Organ Donor Network: a model registry for living kidney donors. Clin Transplant (2004) 1.12
Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure. Hepatology (2013) 1.11
Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys (2003) 1.05
Computer-delivered screening and brief intervention (e-SBI) for postpartum drug use: a randomized trial. J Subst Abuse Treat (2013) 1.05
IL-7 + IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo. Breast Cancer Res Treat (2009) 1.03
Insurance and inpatient care: differences in length of stay and costs between surgically treated cancer patients. Cancer (2012) 1.03
Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients. J Transl Med (2013) 1.03
Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis. Breast Cancer Res Treat (2008) 0.98
Successful adoptive immunotherapy with vaccine-sensitized T cells, despite no effect with vaccination alone in a weakly immunogenic tumor model. Cancer Immunol Immunother (2003) 0.97
A gene transcription signature of obesity in breast cancer. Breast Cancer Res Treat (2011) 0.96
Early complexity supports development of motor behaviors in the first months of life. Dev Psychobiol (2012) 0.95
Bevacizumab and breast cancer: what does the future hold? Future Oncol (2012) 0.92
Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells. Breast Cancer Res Treat (2013) 0.92
Imaging multidrug resistance with 4-[18F]fluoropaclitaxel. Nucl Med Biol (2007) 0.92
Driving simulation can improve insight into impaired driving skills in cirrhosis. Dig Dis Sci (2011) 0.92
Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: a prospective study. Liver Transpl (2012) 0.90
Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes. Int Immunol (2004) 0.89
Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions. Surg Clin North Am (2003) 0.88
Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells. Breast Cancer Res Treat (2010) 0.88
Association between adverse childhood experiences and diagnosis of cancer. PLoS One (2013) 0.88
Methyl-binding domain protein 2-dependent proliferation and survival of breast cancer cells. Mol Cancer Res (2011) 0.87
Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure. J Transl Med (2011) 0.87
Evaluation of a new Trypanosoma cruzi antibody assay for blood donor screening. Transfusion (2007) 0.87
ABR in the diagnosis of vestibular schwannomas: a meta-analysis. Am J Otolaryngol (2013) 0.87
Is pain catastrophizing a stable trait or dynamic state in patients scheduled for knee arthroplasty? Clin J Pain (2012) 0.86
Myeloid-derived suppressor cells enhance IgE-mediated mast cell responses. J Leukoc Biol (2013) 0.86
Phenotype, functions and fate of adoptively transferred tumor draining lymphocytes activated ex vivo in mice with an aggressive weakly immunogenic mammary carcinoma. BMC Immunol (2010) 0.85
Interventions associated with an increased or decreased likelihood of pain reduction and improved function in patients with adhesive capsulitis: a retrospective cohort study. Phys Ther (2009) 0.85
Sensitivity of expanded-criteria donor kidneys to cold ischaemia time. Clin Transplant (2004) 0.84
Predictors of length of stay following colorectal resection for neoplasms in 183 Veterans Affairs patients. World J Surg (2009) 0.83
Variability in the management of idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg (2011) 0.82
Two-year experience with aerobic culturing of apheresis and whole blood-derived platelets. Transfusion (2006) 0.82
Disparity in left ventricular stimulation among different pacing configurations in cardiac resynchronization therapy. Circ Arrhythm Electrophysiol (2011) 0.81
Ex vivo expansion of tumor-reactive T cells by means of bryostatin 1/ionomycin and the common gamma chain cytokines formulation. J Vis Exp (2011) 0.81
Sensitized patients require sharing of highly matched kidneys. Transplantation (2002) 0.81
Tumor bed boost omission after negative re-excision in breast-conservation treatment. Ann Surg Oncol (2006) 0.79
Human dosimetry and preliminary tumor distribution of 18F-fluoropaclitaxel in healthy volunteers and newly diagnosed breast cancer patients using PET/CT. J Nucl Med (2011) 0.79
Taking action on the volume-quality relationship: how long can we hide our heads in the colostomy bag? J Natl Cancer Inst (2003) 0.78
Human leukocyte antigens DR and AB and kidney retransplantation. Transplantation (2003) 0.78
Measuring circulating tumor cells as a surrogate end point for adjuvant therapy of breast cancer: what do they mean and what should we do about them? J Clin Oncol (2008) 0.78
Intraoperative injection of radiocolloid for sentinel node biopsy in breast cancer. J Nucl Med Technol (2013) 0.78
Comparison of different pacing strategies to minimize phrenic nerve stimulation in cardiac resynchronization therapy. J Cardiovasc Electrophysiol (2013) 0.77
Use of laryngeal mask airway in pediatric adenotonsillectomy. Arch Otolaryngol Head Neck Surg (2011) 0.77
The role of margin status and reexcision in local recurrence following breast conservation surgery. Ann Surg Oncol (2013) 0.76
Sentinel node mapping identifies vaccine-draining lymph nodes with tumor-specific immunological activity. Ann Surg Oncol (2002) 0.76
Earlier chemotherapy for breast cancer: perhaps too late but still useful. Ann Surg Oncol (2003) 0.76
Peripheral tissue oxygenation improves during ED treatment of acute heart failure. Am J Emerg Med (2011) 0.76
Economic terms of surgical practice. Ann Surg Oncol (2005) 0.75
Sentinel node micrometastases and non-sentinel nodes in breast cancer: how much do we need to know? J Clin Oncol (2006) 0.75
Surveillance Endomyocardial Biopsy in the Modern Era Produces Low Diagnostic Yield for Cardiac Allograft Rejection. Transplantation (2015) 0.75
Completion axillary lymph node dissection for breast cancer: immediate versus delayed versus none. J Clin Oncol (2008) 0.75
Adoptive cellular therapy of cancer: exploring innate and adaptive cellular crosstalk to improve anti-tumor efficacy. Future Oncol (2014) 0.75
A Stress Coping App for Hospitalized Pregnant Women at Risk for Preterm Birth. MCN Am J Matern Child Nurs (2017) 0.75
Vasodilatation vs. immunotherapy to prevent delayed graft function: delayed graft function as an indication of immune activation. Int Immunopharmacol (2005) 0.75
The impact of physician and hospital volume on the quality of surgical outcomes. J Surg Oncol (2003) 0.75
Reaping the harvest from neoadjuvant therapy for breast cancer: reducing morbidity with sentinel lymph node biopsy. J Surg Oncol (2007) 0.75
Erratum: Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus. Sci Rep (2016) 0.75
The first documented cardiac arrest rhythm in hospitalized patients with heart failure. Resuscitation (2009) 0.75
Brain Integrity Changes underlying Cognitive and Functional Recovery Postliver Transplant Continue to Evolve Over 1 Year. Transplantation (2017) 0.75
Impact of congestive heart failure treatment on peripheral microvascular tissue oxygenation. Congest Heart Fail (2011) 0.75
T-piece resuscitator versus self-inflating bag for preterm resuscitation: an institutional experience. Respir Care (2012) 0.75